Notify me when Najat Khan files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Chief R&D Commercial Officer, Director | $2,694,983 | -$750,765 | -22% | 22 Dec 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|